ArticlePDF Available

In vitro anti-malarial activity of 20 quinones isolated from four plants used by traditional healers in the Democratic Republic of Congo

Authors:

Abstract and Figures

The anti-malarial activity of 20 quinones isolated from Cassia alata, Cassia occidentalis, Garcinia kola and Ocimum basilicum was investigated in vitro using the micro dilution test of Desjardin by a visual evaluation on thin blood smears. The six quinones isolated from C. occidentalis, three from C. alata and three from O. basilicum were found to be the most active with an IC(50) value of below 1 mu g/ml. The others quinones showed a moderate activity with IC(50) values of between 5 and 20 mu g/ml.
Content may be subject to copyright.
Journal of Medicinal Plants Research Vol. 4(11), pp. 991-994, 4 June, 2010
Available online at http://www.academicjournals.org/JMPR
ISSN 1996-0875 ©2010 Academic Journals
Full Length Research Paper
In vitro anti-malarial activity of 20 quinones isolated
from four plants used by traditional healers in the
Democratic Republic of Congo
J. S. Kayembe*, K. M. Taba, K. Ntumba, M. T. C. Tshiongo and T. K. Kazadi
*Department of Chemistry, Faculty of Sciences, University of Kinshasa, Democratic Republic of Congo, P. O. Box 190,
Kinshasa XI.
Accepted 28 January, 2010
The anti-malarial activity of 20 quinones isolated from Cassia alata, Cassia occidentalis, Garcinia kola
and Ocimum basilicum was investigated in vitro using the micro dilution test of Desjardin by a visual
evaluation on thin blood smears. The six quinones isolated from C. occidentalis, three from C. alata and
three from O. basilicum were found to be the most active with an IC50 value of below 1 µg/ml. The others
quinones showed a moderate activity with IC50 values of between 5 and 20 µg/ml.
Key words: Cassia alata, Cassia occidentalis, Garcinia kola, Ocimum basilicum, quinones, anti-malarial
activity, in vitro.
INTRODUCTION
Malaria accounts for 1 - 3 million deaths yearly
worldwide, with most of this burden occurring in children
under 5 years of age in sub - Saharan Africa (Breman
2001). In Kinshasa, Democratic Republic of the Congo,
malaria is prevalent in pupils in suburbs where most of
poor people live (Kazadi et al., 2004). An ethno botanical
survey carried out in these areas had shown that more
than 70% of populations use plants to treat fever
(supposed to be malaria) (Ngalamulume et al., 1995). 58
species of plants and recipes commonly used were
identified. Among those, Cassia alata, Cassia
occidentalis, Garcinia. kola and Ocimum basillicum were
the most frequently used (Kasuku et al., 1999).
The intolerable burden of malaria can be conquered by,
among other things, searching new molecules with potent
anti - malarial activity in plants which always have been
the most common sources of medicines.
The aim of the present work is to evaluate in vitro anti -
malarial activities of 20 quinones isolated from these four
plants: C. alata (4), C. occidentalis (6), G. kola seeds (5)
and O. basillicum (5). In the chemotherapy of malaria,
most molecules belong to the class of alkaloids (Federici
et al., 2000; Andrade – Neto et al., 2003; Zirihi et al.,
*Corresponding author. E-mail: jeanksm@unikin.cd.
2005) and terpenes (Li et al., 1992). The class of
quinones has few representative such as Atovaquone
(Fowler et al., 1994; Basco et al., 1995), Lapachol and
Lapinone (The Merck Index 2005). Quinones as
antimalarial are attracting attention recently
(Kanokmedhakul et al., 2005; Laurent et al., 2006; Eyong
et al., 2006) and the present investigation is in line with
this interest.
MATERIALS AND METHODS
Plant materials
Plants were collected in Kinshasa/ Kisenso, Democratic Republic of
Congo and were authenticated by the Herbarium service of
Department of Biology, University of Kinshasa where voucher
specimens are preserved. The leaves and seeds were air dried at
room temperature for 20 days and then grinded with pestle and
mortar.
Preparation of crude ethanol extract
Crude ethanol extracts were prepared for primary in vitro anti-
malarial assay. The dried and grinded leaves or seeds (20 g) were
extracted with ethanol (2 ×1 L) at room temperature. After the
removal of ethanol in vacuo, the crude extracts obtained were
submitted for anti-malarial test in vitro.
992 J. Med. Plant. Res.
Table 1. In vitro antimalarial activity of crude ethanol extracts.
Plant Concentration ( µg/ml) Growth inhibition %
Cassia alata
Cassia occidentalis
Garcinia kola
Ocimum basilicum
Quinine
25
12.5
25
12.5
n.d
12.5
0.1
83
53
93
24
n.d
78
100
Extraction of quinones
The dried and grinded leaves (200 g) were extracted with methanol
(2 x 2.5 l) at room temperature. The methanol extract was
suspended in a Methanol - H2O 7/3 mixture and then extracted
successively with Petroleum ether (60 - 80°C) and CHCl3.The
CHCl3 fraction was subjected to vacuum liquid chromatography
(VLC) on silica gel previously soaked in a 0.5N oxalic acid solution
and dried over night. The fractions having the same TLC profile
were collected, concentrated together and then submitted each to
column chromatography on silica gel using the following solvent
systems: Pyridine/Amyl alcohol/H2O 4 : 6 : 3 for C. alata quinones;
CHCl3/Ethyl Acetate 5 :1 for C. occidentalis; Ethyl Acetate/
Petroleum Ether 4 :1.2 for G. kola and O. basillicum quinones. Four
fractions (CA1 - CA4) for C. alata, six fractions (CO1 - CO6) for C.
occidentalis, five fractions (GK1 - GK5) for G. kola and five fractions
(OB1 - OB5) for O. basillicum were obtained. All these fractions
showed a positive Borntrager test with a 5% KOH alcoholic
solution.
Anti - malarial activity
The anti - malarial activities of quinones were evaluated in vitro on
their ability to inhibit Plasmodium falciparum growth on RPMI 1640
medium. This method estimates the growth of parasites incubated
in RPMI 1640 medium containing plants extracts in various
concentrations (Desjardins et al., 1979). Parasitemia was
determined on blood smears 48 h after extracts and parasites
contact (Benoit et al., 1996). The IC50 values were determined
graphically in terms of concentration versus inhibition percentage.
RESULTS AND DISCUSSION
Ethanol extracts
Screening the anti - malarial activity of crude extracts is a
first step in the isolation of new molecules with potent
activity (Ma, Zhang and al. 2006; Njoroge G.N. and
al.2006). Anti - malarial activities results of crude ethanol
extracts (Table 1) show that for a concentration of 25
µg/ml, C. occidentalis extract is the most active with 93%
of plasmodium growth inhibition compared to the others
crude extracts. C. occidentalis extracts have been
reported to possess various biological activities (Sharma
et al., 2000; Bin-Hafeez et al., 2001). The anti malarial
activities of C. occidentalis and G. kola have been
reported by Tona et al. (2001). It is likely that these
activities could be attributed to the presence of quinones
in these plants. The Petroleum Ether and ethanol extracts
of C. alata are reported to have a potent inhibitory activity
against Chrysomya megacephale (Kumarasinghe et al.,
2002) and against opportunistic HIV patients’ infections
(Crockett et al., 1992). Ocimum genus species are known
to have antimicrobial, antispasmodic and mosquitoes
repellent effects (Fatope he results obtained for the 20
quinones are summarized in (Table 2). 12 quinones (CO1
- CO6; CA1, CA2 and CA4; OB1, OB2 and OB4) were found
to be the most active with the IC50 values below 1 µg/ml.
4 quinones showed an acceptable activity with the IC50
values between 1 and 5.5 µ/ml. The others have shown a
low activity (IC50 > 10 µg/ml).
Natural quinones have benzoquinone, naphtoquinone
or anthraquinone structures. A growing interest is granted
to these compounds from the description of the
antimalarial activity of Atovaquone (Basco et al., 1995).
Three quinones isolated from Salacia krausii presented
very high activity on P. falciparum (Figueiredo et al.,
1998). Weiss et al. reported a good in vitro antimalarial
activity for Naphthoquinones isolated from Kigelia pinnata
with IC50 values around 0.002 µg/ml (Weiss et al., 2000).
This naphtoquinone is more active than all isolated by us.
A new Xestoquinone isolated in Vanuatu from a marine
sponge (Xestospongia sp.) exhibited also an interesting
inhibitory activity on plasmodium growth with an IC50
value of 3 µM (Laurent et al., 2006). These results added
to ours, showed that quinones are compounds with an
interesting antimalarial activity. They could be used as
starting point for the synthesis of molecules much more
active such as the reported synthesis of an
aminonaphtoquinone which has shown a IC50 of 37,3
ng/ml (Kapadia et al., 2001).
Conclusion
Quinones isolated from C. alata, C. occidentalis, G. kola
and O. basilicum have interesting antimalarial activities
(IC50 < 1 µg/ml for 12 of them). Further investigations are
required in order to characterize the isolated compounds.
Kayembe et al. 993
Table 2. In vitro IC50 (µg/ml) of isolated quinones against Plasmodium falciparum.
Plant Isolated quinone Rf IC
50
(µg/ml)
Cassia alata (leaves)
CA
1
0.61 <0.1
CA
2
0.70 5.4
CA
3
0.86 0.54
CA4
0.92
<0.25
Cassia occidentalis (leaves)
CO
1
0.17 0.25
CO
2
0.28 0.25
CO
3
0.33 <1
CO
4
0.53 0.25
CO
5
0.64 <0.1
CO6
0.84
<0.1
Garcinia kola (seeds)
GK
1
0.17 1.02
GK
2
0.25 2.0
GK
3
0.42 12.9
GK
4
0.54 15.75
GK5
0.85
n.d
Ocimum basilicum (leaves)
OB
1
0.12 0.52
OB
2
0.23 <0.35
OB
3
0.50 1.42
OB
4
0.63 <0.35
OB5
0.88
18
Naphthoquinones (Kigelia pinnata)* 0.002
Aminonaphtoquinones** 37.3 ng/ml**
Chloroquine
72 ng/ml**
*Weiss et al. (2000).
**Reported by Kapadia et al. (2001).
REFERENCES
Andrade-Neto VF, Brandao MGL, Stehmann JA, Oliveira LA, Krettli AU
(2003). Antimalarial Activity of Cinchona-like species plants used to
treat fever and malaria in Brazil. J. Ethnopharmacol. 87(2-3): 253-
256.
Basco LK, Ramiliarisoa O, Le Bras J, (1995). In vitro activity of
atovaquone against the African Isolates and clones of Plasmodium
falciparum. Am. J. Trop. Med. 53(4): 388-391.
Benoît F, Valentin A, Pellisier Y, Diafouka F, Marion C, Kone – Bamba
D, Kone M, Yapo A, Bastide JM (1996). In vitro antimalarial activity
of vegetal extracts used in West African Traditional Medicine. Am. J.
Trop. Med. Hyg. 54(1): 67-71.
Bin-Hafeez B, Ahmad I, Haque R, Raisuddin S (2001). Protective effect
of Cassia occidentalis L. on Cyclophosphamide-induced suppression
of humoral immunity in mice. J. Ethnopharmacol. 75(1): 13-18.
Breman JG (2001). The ears of the hippopotamus: manifestations,
determinants and estimates of the Malaria burden. Am. J. Trop. Med.
Hyg. 64(Suppl. 1-2): 1– 11.
Crockett CO, Guede-Guina F, Pugh D, Vangah-Manda M, Robinson TJ,
Olubadewo JO, Ochillo RF (1992). Cassia alata and the preclinical
search for therapeutic agents for The treatment of opportunistic
infections in AIDS patients. Cell. Mol. Biol. 38(7): 799-802.
Eyong KO, Folefoc GN, Kuete V, Beng P, Krohn K, Hussain H,
Nkengfack AE, Saeftel M, Sarite SR, Hoerauf A (2006). A
naphthoquinone-anthraquinone ether coupled pigment, as a
potential antimicrobial and antimalarial agent from Newbouldia laevis.
Phytochemistry 67(6): 605-609.
Eyong KO, Folefoc GN, Kuete V, Beng VP, Krohn K, Hussain H,
Nkengfack AE, Saeftel M, Sarite SR, Hoerauf A (2006). A
naphthoquinone-anthraquinone ether coupled pigment, as a potential
antimicrobial and antimalarial agent from Newbouldia laevis.
Phytochemistry 67(6): 605-609.
Fatope MO, Takeda Y (1988). The constituents of the leaves of
Ocimum basilicum. Planta. Med. 542: 190-191.
Federicci E, Palazzino G, Nicoletti M, Caleffi C (2000). Antiplasmodial
activity of the alkaloids of Paschiera fuchsiaefolia. Planta. Med. 66(1):
93-95.
Figueiredo JN, Raz B, Sequin U (1998). Novel quinone methides from
Salacia kraussii with in vitro Antimalarial activity. J. Nat. Prod. 61(6):
718-723.
Fowler RE, Billingsley PF, Pudney M, Sinden RE (1994). Inhibitory
action of the antimalarial compound atovaquone (566C80) against
Plasmodium berghei ANKA in mosquito, Anopheles stphensi.
Parasitology 108(Part 4): 383-388.
Kanockmedhakul M, Kanockmedhakul S, Phatchana R (2005).
Biological activity of Anthraquinones and Triterpenoids from
Prismatomeris fragrans. J. Ethnopharmacol. 100(3): 284-288.
Kapadia GJ, Azuine MA, Balasubramanian V, Sridhar R (2001).
Amininoquinones: a novel class of compounds with potent
antimalarial activity against Plasmodium falciparum; Pharmacol. Res.
994 J. Med. Plant. Res.
43(4): 363-367.
Kazadi W, Sexton JD, Bigoma M, W’Okanga B, Way M (2004). Malaria
in primary school Children and infants in Kinshasa. Democratic
Republic of Congo. Am. J. Trop. Med. Hyg. 71(Suppl. 2): 97-102.
Kumarasinghe SP, Karunaweera ND, Ihalamulla RL, Arambewela LS,
Dissanayake RD (2002). Larvicidal effects of mineral turpentine, low
aromatic white spirits, aqueous extracts of Cassia alata, and aqueous
extracts, ethanolic extracts and essential oil of betel leaf (Piper betel)
on Chrysomya megacephala. Int. J. Dermatol. 41(12): 877-880.
Laurent D, Jullian V, Parenty A, Knibiehler M, Dorin D, Schmitt S,
Lozach O, Lebouvier N, Frostin M, Alby F, Maura S, Doerig C, Meijer
L, Savant M (2006). Antimalarial potential of xestoquinone, a protein
kinase inhibitor isolated from a Vanuatu marine Sponge
Xestospongia sp. Bioorg. Med. Chem. 14(13): 4477-4482.
Li X, Rieckmann K (1992). A bioassay for derivatives of Qinghaosu
(artemisinin) Trop. Med. Parasitol. 43: 195-196.
Ma C, Zhang HJ, Tan GT, Hung NV, Cuong NM, Soejarto DD, Fong HH
(2006). Antimalarial compounds from Grewia bilamellata J. Nat. Prod.
69(3): 346-350.
Njoroge GN, Bussmann RW (2006). Diversity and utilization of
antimalarial ethnophytotherapeutic Remedies among the Kikuyus
(Central Kenya). J. Ethnobiol. Ethnomedicine 2: 8.
Sharma N, Trikha P, Athar M, Raisuddin S (2000). In vitro inhibition of
carcinogen induced mutagenicity by Cassia occidentalis and Emblica
officinalis. Drug Chem. Toxicol. 23(3): 477-484.
Skaltsa H, Philianos S (1986). Chemical study of Ocimum basilicum L.
Part 1: Plant. Med. Phytother. 20(4): 291-299.
The Merck Index: An Encyclopaedia of Chemicals and Drugs.13th
Edition Merck and Co., Inc Rahway. N.J. USA. (2005).
Tona L, Mesia K, Ngimbi NP, Chrimwami B, Okond'ahoka, Cimanga K,
de Bruyne T, Apers S, Hermans N, Totte J, Pieters L, Vlietinck AJ
(2001). In-vivo antimalarial activity of Cassia occidentalis, Morinda
morindoides and Phyllanthus niruri. Ann. Trop. Med. Parasitol. 95(1):
47-57.
Weiss CR, Moideen SV, Croft SL, Hougton PJ (2000). Activity of
extracts and isolated Naphthoquinones from Kigelia pinnata against
Plasmodium falciparum. J. Nat. Prod. 63(9): 1306-1309.
Zihiri GN, Grellier P, Guede – Gina F, Bodo B, Mambu L (2005).
Isolation, characterization and antiplasmodial activity of steroidal
alkaloids from Funtumia elastica (Preuss) Stapf. Bioorg. Med. Chem.
Lett. 16(10): 2637- 2640.
... Several Senna species are typically used in herbal medicines and foods [115]. These plants contain, among others, important bioactive compounds such as terpenes, alkaloids and quinones [116][117][118][119][120]. Aqueous extracts of Senna leaves granted relief from SARS-CoV-2 symptoms in patients [88] and are being explored as a potential herbal therapy against SARS-CoV-2. ...
Article
Full-text available
Abstract: The current century has witnessed infections of pandemic proportions caused by Coron�aviruses (CoV) including severe acute respiratory syndrome-related CoV (SARS-CoV), Middle East respiratory syndrome-related CoV (MERS-CoV) and the recently identified SARS-CoV2. Significantly, the SARS-CoV2 outbreak, declared a pandemic in early 2020, has wreaked devastation and imposed intense pressure on medical establishments world-wide in a short time period by spreading at a rapid pace, resulting in high morbidity and mortality. Therefore, there is a compelling need to combat and contain the CoV infections. The current review addresses the unique features of the molecular virology of major Coronaviruses that may be tractable towards antiviral targeting and design of novel preventative and therapeutic intervention strategies. Plant-derived vaccines, in particular oral vaccines, afford safer, effectual and low-cost avenues to develop antivirals and fast response vaccines, requiring minimal infrastructure and trained personnel for vaccine administration in developing countries. This review article discusses recent developments in the generation of plant-based vaccines, therapeutic/drug molecules, monoclonal antibodies and phytochemicals to preclude and combat infections caused by SARS-CoV, MERS-CoV and SARS-CoV-2 viruses. Efficacious plant-derived antivirals could contribute significantly to combating emerging and re-emerging pathogenic CoV infections and help stem the tide of any future pandemics.
... In general, the IC 50 s obtained for the antiplasmodial activity of S. alata were less than those reported by other researchers. The IC 50 of 0.14 µg/ml for the ethanolic leaf extract and 0.47 µg/ml for the alkaloid, of S. alata were less in comparison to the one (12.5 µg/ml) reported by Kayembe et al. [31] when they tested the antiplasmodial effects of the ethanolic seed extract. Jouse et al. [32] obtained an IC 50 of 0.48 µg/ml and 0.67 µg/ml for the methanolic and aqueous extracts, respectively. ...
Article
Full-text available
Objectives: Malaria morbidity and mortality rates are worsening, despite the dedicated commitment to eradicate the infestation, principally because of failing chemotherapy, the mainstay of treatment, and lack of registered vaccine. Therefore, the search for more potent antimalarial agents has become urgent and imperative. Hence, in this study, the cytotoxicity and antiplasmodial activity of the ethanolic leaf extracts and alkaloid fractions of eight 8African medicinal plants used in Nigerian traditional medicine were evaluated using standard methods and documented procedures. Materials and Methods: In vitro antiplasmodial activity was assessed using 3D7 chloroquine-sensitive strain of Plasmodium falciparum maintained at 5% hematocrit (human type O-positive red blood cells) in complete RPMI 1640 medium, while cytotoxicity was determined by the microassay technique using L929 animal cell fibroblasts by the lactate dehydrogenase method. Results: Results indicate that the ethanolic leaf extracts of six out of the eight plants (Tridax procumbens, Ipomoea purpurea, Sida acuta, Senna alata, Phyllanthus amarus, Azadirachta indica, Nauclea latifolia, and Polyalthia longifolia) studied were non-toxic (CC 50 range: 33.88-954.99 µg/ml; and Chloroquine, CQ: 79.43µg/ml), but T. procumbens and S. acuta showed mild toxicity (CC 50 =23.99µg/ml for each plants) as judged by the standard reference (CC 50 : 30µg/ml= non-toxic). However, all leaf extracts of the eight plants demonstrated significant (P < 0.05) growth inhibition of P. falciparum (IC 50 range: 0.05-0.28µg/ml, CQ: 0.03 µg/ml, standard reference: ≤5 µg/ml=highly active) with very highly rated selectivity index, (SI), values (range: 343-3990, CQ: 2648, reference: >10=selectable). In addition, the alkaloid fractions of the eight plants showed no toxicity (CC 50 :44.67-954.99 µg/ml) and had very active antiplasmodial activity (IC 50 : 0.23-2.04µg/ml) with great SI figures (22-2942). Alkaloids from P. amarus, A. indica, N. latifolia, and P. longifolia were particularly reputable (SI=2942, 1361, 2081, and 1516, respectively) for selection. Conclusion: This in vitro study confirms the antiplasmodial activity of these plants and justifies their use in the Nigerian tradomedicine, but further identified the alkaloid constituent as the medicinal phytochemical responsible for the observed antiplasmodial activity. Alkaloids from especially the four notable plants with high SI should, therefore, be characterized with the hope of discovering novel agent(s) against malaria.
Article
Full-text available
Malaria is one of the most devastating diseases across the globe, particularly in low-income countries in Sub-Saharan Africa. The increasing incidence of malaria morbidity is mainly due to the shortcomings of preventative measures such as the lack of vaccines and inappropriate control over the parasite vector. Additionally, high mortality rates arise from therapeutic failures due to poor patient adherence and drug resistance development. Although the causative pathogen (Plasmodium spp.) is an intracellular parasite, the recommended antimalarial drugs show large volumes of distribution and low-to no-specificity towards the host cell. This leads to severe side effects that hamper patient compliance and promote the emergence of drug-resistant strains. Recent research efforts are promising to enable the discovery of new antimalarial agents; however, the lack of efficient means to achieve targeted delivery remains a concern, given the risk of further resistance development. New strategies based on green nanotechnologies are a promising avenue for malaria management due to their potential to eliminate malaria vectors (Anopheles sp.) and to encapsulate existing and emerging antimalarial agents and deliver them to different target sites. In this review we summarized studies on the use of plant-derived nanoparticles as cost-effective preventative measures against malaria parasites, starting from the vector stage. We also reviewed plant-based nanoengineering strategies to target malaria parasites, and further discussed the site-specific delivery of natural products using ligand-decorated nanoparticles that act through receptors on the host cells or malaria parasites. The exploration of traditionally established plant medicines, surface-engineered nanoparticles and the molecular targets of parasite/host cells may provide valuable insights for future discovery of antimalarial drugs and open new avenues for advancing science toward the goal of malaria eradication.
Article
Full-text available
Context Tanzania has rich medicinal plant (MP) resources, and most rural inhabitants rely on traditional healing practices for their primary healthcare needs. However, available research evidence on antimalarial MPs is highly fragmented in the country. Objective This systematic review compiles ethnomedicinal research evidence on MPs used by Tanzanians as antimalarials. Materials and methods A systematic web search was conducted using various electronic databases and grey materials to gather relevant information on antimalarial MPs utilized by Tanzanians. The review was per the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. The data were collected from 25 articles, and MS Excel software was used to analyse relevant ethnobotanical information using descriptive statistics. Results A total of 227 MPs belonging to 67 botanical families and 180 genera were identified. Fabaceae (15.9%) is the most frequently utilized family. The ethnobotanical recipes analysis indicated leaves (40%) and trees (44%) are the preferred MPs part and life form, respectively. Decoctions (67%) are the dominant preparation method of remedies. Of the recorded MPs, 25.9% have been scientifically investigated for antimalarial activities with positive results. However, 74.1% of MPs have no scientific records on antimalarial activities, but they could be potential sources of remedies. Conclusions The study discloses a wealth of antimalarial MPs possessed by Tanzanians and suggests a need for research to authenticate the healing potential of antimalarial compounds from the unstudied MPs. Additionally, it indicates that some of the presented MPs are potential sources for developing safe, effective and affordable antimalarial drugs.
Article
Full-text available
Cassia species have a long history of utilization in various traditional medicine systems worldwide, and they are widely consumed for medicinal purposes, particularly the officinal species. The aim of this review article is to provide a comprehensive overview of the botany, traditional uses, phytochemistry, and pharmacology of the Cassia genus. A thorough literature review was conducted using major scientific databases, publishers, and online websites such as Science Direct, Scopus, PubMed, Springer, POWO, among others. It is important to note that the taxonomy of the Cassia genus has undergone changes over time, resulting in the reclassification of some plants into the Senna and Chamaecrista genera. Therefore, this review includes relevant data on the three genera: Cassia, Senna, and Chamaecrista spp. The findings of the review indicate that Cassia, Senna, and Chamaecrista spp. have been extensively used for medicinal purposes in various traditional medicine systems, including Traditional Chinese Medicine (TCM), Islamic Traditional Medicine (ITM), Unani medicine, and Ayurveda. These plants have traditionally been employed to treat respiratory and gastrointestinal conditions, as well as skin disorders. In ITM, the reported species include Cassia acutifolia, Cassia fistula, Senna occidentalis, and Senna tora. In TCM, the most commonly used species are Cassia occidentalis, Cassia tora, Senna alexandrina, Senna occidentalis, and Senna singueana. These plants are rich in phytochemicals such as anthraquinones, alkaloids, and flavonoids, which contribute to their diverse pharmacological activities. These activities include antimicrobial, anti-inflammatory, antioxidant, antidiabetic, antiulcer, hypolipidemic, anti-atherosclerotic, and hepatoprotective effects. Based on the available literature, it can be concluded that the Cassia genus possesses significant preventive and therapeutic potential. The rich phytochemical composition and wide range of pharmacological activities make Cassia species a valuable resource in the field of natural medicine.
Article
Full-text available
Background Malaria remains the leading cause of death in sub-Saharan Africa. Although recent developments such as malaria vaccine trials inspire optimism, the search for novel antimalarial drugs is urgently needed to control the mounting resistance of Plasmodium species to the available therapies. The present study was conducted to document ethnobotanical knowledge on the plants used to treat symptoms of malaria in Tororo district, a malaria-endemic region of Eastern Uganda. Methods An ethnobotanical study was carried out between February 2020 and September 2020 in 12 randomly selected villages of Tororo district. In total, 151 respondents (21 herbalists and 130 non-herbalists) were selected using multistage random sampling method. Their awareness of malaria, treatment-seeking behaviour and herbal treatment practices were obtained using semi-structured questionnaires and focus group discussions. Data were analysed using descriptive statistics, paired comparison, preference ranking and informant consensus factor. Results A total of 45 plant species belonging to 26 families and 44 genera were used in the preparation of herbal medicines for management of malaria and its symptoms. The most frequently mentioned plant species were Vernonia amygdalina, Chamaecrista nigricans, Aloe nobilis, Warburgia ugandensis, Abrus precatorius, Kedrostis foetidissima, Senna occidentalis, Azadirachta indica and Mangifera indica. Leaves (67.3%) were the most used plant part while maceration (56%) was the major method of herbal remedy preparation. Oral route was the predominant mode of administration with inconsistencies in the posology prescribed. Conclusion This study showed that the identified medicinal plants in Tororo district, Uganda, are potential sources of new antimalarial drugs. This provides a basis for investigating the antimalarial efficacy, phytochemistry and toxicity of the unstudied species with high percentage use values to validate their use in the management of malaria.
Article
Full-text available
The antiplasmodial effects of Senna alata and Dennettia tripetalla on chloroquine-sensitive Plasmodium berghei berghei (NK65) were analysed. P. berghei was obtained from National Institute for Medical Research, Lagos, Nigeria, and maintained in the laboratory by serial passage in mice. Chemosuppressive, prophylactic, and curative procedures were used to evaluate the antiplasmodial potentials of the extracts against established infection. A total of 320 albino mice were used for this study. Twenty-five albino mice were divided into 5 groups and used for D. tripetalla acute toxicity study. Eighty-five albino mice were divided into 15 groups of five albino mice each and used for chemosuppressive tests while two hundred and ten mice were used for prophylactic and curative tests. The infected mice were orally treated daily with 5mg/kg chloroquine 500 mg/kg, 1000 mg/kg, 1500 mg/kg, and 2000 mg/kg body weight of S. alata, D. tripetalla, and S. alata + D. tripetalla respectively. The in vivo antiplasmodial effect of the extracts against P. berghei infection showed a significant (p?0.05) dose-dependent schizontocidal activity for the chemosuppressive, and prophylactic test. Results of the curative study showed that the combination of both S. alata and D. tripetalla exhibited a strong curative effect on malaria parasitaemia. There was a significant clearance (p?0.05) in parasiteamia level from day 1 to day 5 of treatment in a dose-dependent manner with a corresponding significant (p?0.05) percentage suppression. It was therefore concluded that the leaf extracts of S. alata and D. tripetalla possess antimalarial potencies which could be exploited for antimalarial therapy.
Article
Subjects: Biotechnology & Applied Microbiology Contributor: Srividhya Venkataraman The SARS-CoV2 outbreak, declared a pandemic in early 2020, has wreaked devastation and imposed intense pressure on medical establishments worldwide in a short time period by spreading at a rapid pace, resulting in high morbidity and mortality. Plant-derived vaccines, in particular oral vaccines, afford safer, effectual and low-cost avenues to develop antivirals and fast response vaccines, requiring minimal infrastructure and trained personnel for vaccine administration in developing countries. coronavirus SARS-CoV-2 molecular pharming plant-based vaccines
Chapter
Full-text available
CURRENT COMPREHENSIVE APPROACH TO COVID-19 EDS. PROF.DR. HARUN ALP, PROF.DR. MURAT ÇETİN RAĞBETLİ AND ASST. PROF.DR. HALE KOKSOY
Article
Full-text available
A sensitive bioassay was developed for measuring the serum antimalarial activity for qinghaosu (artemisinin) derivatives. This should assist in the formulation of optimum regimens for the treatment of P. falciparum malaria.
Article
Full-text available
The in vitro activity of atovaquone (566C80) was evaluated and compared with that of chloroquine, quinine, mefloquine, halofantrine, artemether, pyrimethamine, and cycloguanil against African isolates and clones of Plasmodium falciparum using an isotopic, semimicro, drug susceptibility test. Atovaquone was highly active against the chloroquine-susceptible L-3 (geometric mean 50% inhibitory concentration [IC50] = 0.978 nM) and L-16 clones (mean IC50 = 0.680 nM) and against the multidrug-resistant FCM 29 clone (mean IC50 = 1.76 nM). Similar low IC50 values for atovaquone were observed against the chloroquine-susceptible isolates (n = 35; geometric mean IC50 = 0.889 nM) and the chloroquine-resistant parasites (n = 26; geometric mean IC50 = 0.906 nM). The in vitro responses between atovaquone and the other antimalarial drugs were not correlated, indicating the absence of in vitro cross-resistance. The high in vitro activity of atovaquone without any in vitro evidence for cross-resistance with other antimalarial drugs against the naturally occurring malaria parasites is a factor that favors further development of the drug for clinical use.
Article
In our search for therapeutic agents from natural sources with potential for the treatment of opportunistic infections in patients afflicted with acquired immunodeficiency syndrome (AIDS), we investigated antibacterial and antifungal activities of water extracts of Cassia alata (C. alata). The extracts are traditionally used in Ivory Coast, West Africa to treat bacterial infections caused by Escherichia coli (E. coli), and fungal infections caused by Candida albicans (C. albicans) and dermatophytes. Our working hypothesis was that the extract contains active ingredient(s) which can be isolated, identified and developed into useful antibacterial/antifungal agents for the treatment of opportunistic infections in patients with AIDS. We used the broth dilution and agar dilution methods. Specifically, we focused on E. coli and C. albicans and the effectiveness of the extracts was evaluated relative to those of standard antibacterial agent chloramphenicol and antifungal agent amphotericin B. The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) for the water extract of C. alata against E. coli were 1.6 mg/ml and 60 mg/ml, respectively; corresponding data for chloramphenicol were 2 micrograms/ml and 10 micrograms/ml. Similarly, the MIC and minimum fungicidal concentration (MFC) for the extract against C. albicans were 0.39 mg/ml and 60 mg/ml in contrast to 0.58 micrograms/ml and 0.98 micrograms/ml for amphotericin B. From the dose-response curve plots, the extract had an IC50 of 31 mg/ml for E. coli and 28 mg/ml for C. albicans. The data suggest that C. alata extracts contain agent(s) which have therapeutic potential and might be useful if isolated and developed for the treatment of opportunistic infections of AIDS patients.
Article
The activity of atovaquone against Plasmodium berghei ANKA during sporogonic development has been examined. Anopheles stephensi mosquitoes were fed on gametocyte infected mice which had been treated 8 h previously with atovaquone or diluent alone. Mosquito midguts were examined for oocysts, and salivary gland infections were estimated using an ELISA for the circumsporozoite protein (CSP). The number of oocysts per midgut fell by at least 97% when mosquitoes were fed on mice dosed with 0.1-10 mg atovaquone/kg body weight. This was paralleled by a decrease in the prevalence of oocyst-infected mosquitoes from 70-90% in controls to 40% or 10% respectively. No oocysts were observed at a dose of 100 mg/kg. CSP ELISA results indicated that mosquitoes fed on atovaquone failed to produce sporozoites. Mosquitoes which fed on gametocytaemic, atovaquone-treated mice (0.1-100 mg/kg) did not transmit malaria to naive mice. These results demonstrate that atovaquone has a highly potent inhibitory activity against the mosquito stages of P. berghei.
Article
Among strategies for the development of new antimalarials, a study of plants traditionally used in Africa against malaria has been pursued. Extracts obtained from the plants Azadirachta indica, Cinnamonum camphora, Lippia multiflora, Vernonia colorata, Guiera senegalensis, Combretum micranthum, and Ximenia americana, commonly used in Cote d'Ivoire by native healers for the treatment of malaria, were tested on two strains of Plasmodium falciparum: FcB1-Colombia (chloroquine-resistant) and F32-Tanzania (chloroquine-sensitive). Extracts were obtained after infusion and decoction, both techniques being used by most native healers. The antimalarial activities of the extracts were tested first by parasite 3H-hypoxanthine incorporation and second by visual evaluation of the activities of plant extracts on thin blood smears, which also permitted the determination of parasitic stages and parasite alteration. Among the seven plants tested, some had an apparent inhibitory effect on P. falciparum growth in vitro, while other seemed to be less efficient.
Article
Three novel quinone methides, i.e., 28-nor-isoiguesterin-17-carbaldehyde (1), 17-(methoxycarbonyl)-28-nor-isoiguesterin (2), and 28-hydroxyisoiguesterin (3), together with the known celastrol (5), pristimerin (6), and isoiguesterol (7), were isolated from the roots of Salacia kraussii (Celastraceae) by bioassay-guided fractionation. The structures of the compounds were determined by DEPT and 2D NMR techniques. The isolates showed antimalarial activity 30-50-fold greater than their cytotoxicity (in HT-29 cells) in vitro, and they showed an additive effect when combined with each other. In vivo, 2 was found to be inactive against blood stages of Plasmodium berghei in mice after oral and parenteral administration, and the compound was toxic with increasing concentrations.
Article
The tertiary and quaternary alkaloids isolated from the stem bark, root bark and seeds of Peschiera fuchsiaefolia are reported. The tertiary alkaloid crude extract from the stem bark was tested in vitro against Plasmodium falciparum on the basis of the antimalarial use of the plant. It showed good activity against both the D6 strain (IC50 = 495 ng/ml) and chloroquine-resistant W2 strain (IC50 = 817 ng/ml) and voacamine was the most active of the tested alkaloids (IC50 = 238 ng/ml for D6 and 290 ng/ml for W2). The tertiary alkaloid crude extract from the root bark of the same plant is more active than voacamine (IC50 = 179 ng/ml for D6 and 282 ng/ml for W2 strain), and is particularly rich in dimeric alkaloids (0.22% of the vegetable material).
Article
Aqueous extracts of Cassia occidentalis Linn. (Leguminoceae) and Emblica officinalis Gaertn. (Euphorbiaceae) were screened for effectiveness in inhibiting mutagenicity of aflatoxin B1 (AFB1) and benzo[a]pyrene (B[a]P) in the Ames test. Antimutagenicity was evaluated using Salmonella typhimurium strains TA 98 and TA 100. In the assay, metabolic activation of AFB1 (0.5 microg/plate) and B[a]P (1 microg/plate) was mediated by rat liver S9 preparation. Although both plants inhibited mutagenicity, E. officinalis had more inhibitory effect than C. occidentalis. Their action is possibly mediated through interactions with microsomal activating enzymes. Their inhibitory action on chromosomal aberrations together with present results suggest that these plants have potent antimutagenic and anticarcinogenic activities against mutagens requiring metabolic activation.
Article
Four naphthoquinoids from Kigelia pinnata rootbark were assessed in vitro against chloroquine-sensitive (T9-96) and -resistant (K1) Plasmodium falciparum strains and for cytotoxicity using KB cells. 2-(1-Hydroxyethyl)naphtho[2,3-b]furan-4,9-dione possessed good activity against both strains [IC(50) values 627 nM (K1), 718 nM (T9-96)]. Isopinnatal, kigelinol, and isokigelinol exhibited lower activity against both strains.